MICHAEL GIACOUMOPOULOS: Open Payments
NPI 1972110658 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,269 in 68 payments from 15 companies in 2025. Trend: 2023 $1,638 · 2024 $1,931 · 2025 $1,269
Food & beverage: $1,269
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $325 |
| AstraZeneca Pharmaceuticals LP | 9 | $188 |
| Novo Nordisk Inc | 8 | $171 |
| Lilly USA, LLC | 6 | $105 |
| PFIZER INC. | 5 | $104 |
| Amgen Inc. | 3 | $73 |
| Exact Sciences Corporation | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
Products named: VRAYLAR, AIRSUPRA, Wegovy, MOUNJARO, NURTEC ODT, QULIPTA, Rybelsus, UBRELVY.
Industry payments across PA — which companies pay providers there.
